MEIP

MEI Pharma to Present at Bank of America Merrill Lynch and UBS Healthcare Conferences

[PR Newswire] – SAN DIEGO, May 8, 2014 /PRNewswire/ — MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is […]

MEI Pharma Initiates Clinical Study Of Mitochondrial Inhibitor Drug Candidate ME-344 In Small Cell Lung And Ovarian Cancers

[PR Newswire] – SAN DIEGO, May 5, 2014 /PRNewswire/ — MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of i moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view […]

8:34 am MEI Pharma. identifies potential biomarker for Pracinostat in bladder cancer; new pre-clinical data presented at AACR annual meeting in San Diego

moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is hiring next, click here to view […]

8:36 am MEI Pharma confirmed that the U.S. Food and Drug Administration has granted orphan drug designation to the Co’s investigational drug Pracinostat for the treatment of acute myeloid leukemia

moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is hiring next, click here to view […]

8:36 am MEI Pharma confirmed that the U.S. Food and Drug Administration has granted orphan drug designation to the Co’s investigational drug Pracinostat for the treatment of acute myeloid leukemia

moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is hiring next, click here to view […]

MEI Pharma Receives Orphan Status For Lead Drug Candidate Pracinostat For Treatment Of Acute Myeloid Leukemia

[PR Newswire] – SAN DIEGO, Feb. 28, 2014 /PRNewswire/ — MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan d moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI […]

MEI Pharma To Present At Cowen Health Care And ROTH Conferences

[PR Newswire] – SAN DIEGO, Feb. 25, 2014 /PRNewswire/ — MEI Pharma, Inc. (MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, wi moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is […]

MEI PHARMA, INC. Financials

moreView todays social media effects on MEIPView the latest stocks trending across Twitter. Click to view dashboardSee who MEI is hiring next, click here to view […]